Literature DB >> 24117397

Development of a composite measure of state-level malpractice environment.

Jeanette W Chung1, Min-Woong Sohn, Ryan P Merkow, Elissa H Oh, Christina Minami, Bernard S Black, Karl Y Bilimoria.   

Abstract

OBJECTIVE: To develop a composite measure of state-level malpractice environment. DATA SOURCES: Public use data from the National Practitioner Data Bank, Medical Liability Monitor, the National Conference of State Legislatures, and the American Bar Association. STUDY
DESIGN: Principal component analysis of state-level indicators (paid claims rate, malpractice premiums, lawyers per capita, average award size, and malpractice laws), with indirect validation of the composite using receiver-operating characteristic curves to determine how accurately the composite could identify states with high-tort activity and costs. PRINCIPAL
FINDINGS: A single composite accounted for over 73 percent of total variance in the seven indicators and demonstrated reasonable criterion validity.
CONCLUSION: An empirical composite measure of state-level malpractice risk may offer advantages over single indicators in measuring overall risk and may facilitate cross-state comparisons of malpractice environments. © Health Research and Educational Trust.

Keywords:  State health policies; health policy; observational data

Mesh:

Year:  2013        PMID: 24117397      PMCID: PMC3976196          DOI: 10.1111/1475-6773.12110

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  8 in total

1.  The impact of malpractice fears on cesarean section rates.

Authors:  L Dubay; R Kaestner; T Waidmann
Journal:  J Health Econ       Date:  1999-08       Impact factor: 3.883

2.  Crime: social disorganization and relative deprivation.

Authors:  I Kawachi; B P Kennedy; R G Wilkinson
Journal:  Soc Sci Med       Date:  1999-03       Impact factor: 4.634

3.  The frequency and severity of medical malpractice claims: new evidence.

Authors:  P M Danzon
Journal:  Law Contemp Probl       Date:  1986

4.  The growth of physician medical malpractice payments: evidence from the National Practitioner Data Bank.

Authors:  Amitabh Chandra; Shantanu Nundy; Seth A Seabury
Journal:  Health Aff (Millwood)       Date:  2005 Jan-Jun       Impact factor: 6.301

Review 5.  Methodological issues in determining the dimensionality of composite health measures using principal component analysis: case illustration and suggestions for practice.

Authors:  Joël Coste; Stéphane Bouée; Emmanuel Ecosse; Alain Leplège; Jacques Pouchot
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

6.  Malpractice liability costs and the practice of medicine in the Medicare program.

Authors:  Katherine Baicker; Elliott S Fisher; Amitabh Chandra
Journal:  Health Aff (Millwood)       Date:  2007 May-Jun       Impact factor: 6.301

7.  Malpractice risk according to physician specialty.

Authors:  Anupam B Jena; Seth Seabury; Darius Lakdawalla; Amitabh Chandra
Journal:  N Engl J Med       Date:  2011-08-18       Impact factor: 91.245

8.  Defensive medicine among high-risk specialist physicians in a volatile malpractice environment.

Authors:  David M Studdert; Michelle M Mello; William M Sage; Catherine M DesRoches; Jordon Peugh; Kinga Zapert; Troyen A Brennan
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

  8 in total
  2 in total

1.  Physician Network Connections Associated With Faster De-Adoption of Dronedarone for Permanent Atrial Fibrillation.

Authors:  Chad Stecher; Alexander Everhart; Laura Barrie Smith; Anupam Jena; Joseph S Ross; Nihar R Desai; Nilay Shah; Pinar Karaca-Mandic
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-09-24

2.  Physician variation in the de-adoption of ineffective statin and fibrate therapy.

Authors:  Alexander Everhart; Nihar R Desai; Bryan Dowd; Jeph Herrin; Lucas Higuera; Molly Moore Jeffery; Anupam B Jena; Joseph S Ross; Nilay D Shah; Laura Barrie Smith; Pinar Karaca-Mandic
Journal:  Health Serv Res       Date:  2021-02-10       Impact factor: 3.734

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.